Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.210 | 3.210 | 0.000 |
Shares | 96.790 | 96.790 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 29.119 | 24.086 |
Price to Book | 10.284 | 4.527 |
Price to Sales | 5.423 | 3.307 |
Price to Cash Flow | 22.968 | 15.927 |
Dividend Yield | 1.382 | 1.224 |
5 Years Earnings Growth | 9.992 | 12.407 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 31.950 | 16.367 |
Consumer Defensive | 31.600 | 7.992 |
Technology | 12.830 | 26.755 |
Financial Services | 9.210 | 13.512 |
Consumer Cyclical | 8.150 | 12.487 |
Industrials | 6.260 | 11.825 |
Number of long holdings: 25
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
L'Oreal | FR0000120321 | 5.74 | 447.60 | -1.30% | |
Intuit | US4612021034 | 5.08 | 661.18 | +1.20% | |
Waters | US9418481035 | 4.88 | 355.84 | -1.30% | |
Microsoft | US5949181045 | 4.79 | 420.21 | -0.19% | |
Visa A | US92826C8394 | 4.58 | 280.11 | +0.10% | |
Novo Nordisk A/S Class B | DK0060534915 | 4.52 | - | - | |
Stryker | US8636671013 | 4.48 | 334.88 | +0.27% | |
Church&Dwight | US1713401024 | 4.48 | 106.39 | -0.27% | |
PayPal | US70450Y1038 | 4.33 | 64.48 | +0.59% | |
J&J | US4781601046 | 4.33 | 154.68 | +0.26% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Inc | 4.72B | 7.14 | 5.85 | 15.68 | ||
Fundsmith Equity R Acc | 616.56M | 6.92 | 5.21 | 14.98 | ||
Fundsmith Equity R Inc | 17.99M | 6.92 | 5.21 | 14.97 | ||
Fundsmith Equity T Acc | 4.27B | 7.10 | 5.74 | 15.57 | ||
Fundsmith Equity T Inc | 277.78M | 7.10 | 5.74 | 15.56 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review